SS

Sonali Sarkar

Active Director Director DIN 03012121
DIN 03012121 First appointment Jul 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Sonali Sarkar

Data last updated:

Sonali Sarkar is a Director at Sarala Pharma Private Limited (since 2015). The company operates in Pharma. Sarala Pharma Private Limited reported revenue of ₹2.20 Cr (FY 2024).

DIN 03012121
Primary Designation Director
Industry Pharma
First Appointment 20 Jul 2015
Oldest Company Age 11 yrs
Largest company Sarala Pharma Private Limited · ₹2.20 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sarala Pharma Private Limited U74900WB2015PTC207151
Director20 Jul 20152015₹2.20 Cr (FY 2024)Active

Board colleagues of Sonali Sarkar

NameDINCompanyDesignation
Malay Sarkar03012141Sarala Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sarala Pharma Private Limited
Premium access

Shareholding and investment profile for Sonali Sarkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonali Sarkar

Sonali Sarkar currently holds 1 directorship: Sarala Pharma Private Limited (Director, since 20 Jul 2015, revenue ₹2.20 Cr (FY 2024)).

Sonali Sarkar was first appointed on 20 Jul 2015 as Director at Sarala Pharma Private Limited.

The current boards of Sonali Sarkar's companies include Malay Sarkar (Sarala Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available